Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
126,404,443
-
Total 13F shares
-
58,051,832
-
Share change
-
+391,270
-
Total reported value
-
$283,327,408
-
Put/Call ratio
-
87%
-
Price per share
-
$4.88
-
Number of holders
-
140
-
Value change
-
-$3,172,672
-
Number of buys
-
75
-
Number of sells
-
71
Institutional Holders of Organogenesis Holdings Inc. - Common Stock, $0.0001 par value per share (ORGO) as of Q2 2022
As of 30 Jun 2022,
Organogenesis Holdings Inc. - Common Stock, $0.0001 par value per share (ORGO) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,051,832 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, Soleus Capital Management, L.P., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, MORGAN STANLEY, FEDERATED HERMES, INC., Assenagon Asset Management S.A., GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
140
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.